Status:

WITHDRAWN

LIBERATE Trial in COVID-19

Lead Sponsor:

King's College London

Conditions:

Coronavirus

Respiratory Distress Syndrome

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The study aims to evaluate the reduction in severity and progression of lung injury with three doses of lipid ibuprofen in patients with SARS-CoV-2 infections.

Eligibility Criteria

Inclusion

  • Male or female patients aged 18 years and above;
  • Hospitalised;
  • Confirmed or suspected SARS-CoV-2 infection;
  • National Early Warning Score (NEWS2) greater than or equal to 3 in a single parameter or NEWS2 \> 5 overall;
  • Acute hypoxemic respiratory failure: PaO2/FiO2 ratio less than or equal to 300 OR SpO2/FiO2 ratio \< 315 (Kigali Modification)
  • Provision of written informed consent by the patient OR by the patient's Legal Representative OR professional consultee.

Exclusion

  • Any of the following contraindications to ibuprofen:
  • A known hypersensitivity to ibuprofen or any other constituent of the medicinal product;
  • Patients who have previously shown hypersensitivity reactions (e.g. asthma, rhinitis, angioedema or urticaria) in response to aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs);
  • Patients with a history of, or existing gastrointestinal ulceration/perforation or bleeding, including that associated with NSAIDs;
  • Patients with severe hepatic failure;
  • Patients with acute renal failure;
  • Patients with severe heart failure.
  • Participation in any other investigational drug products less than 30 days prior to study enrolment;
  • Glasgow Coma Score \< 12;
  • Patients who cannot swallow oral capsules;
  • Pregnant or lactating women;
  • Any medical history that might, in the opinion of the attending clinician, put the patient at significant risk if he/she were to participate in the trial.

Key Trial Info

Start Date :

May 26 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 25 2021

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04334629

Start Date

May 26 2020

End Date

September 25 2021

Last Update

July 25 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Guy's and St Thomas' NHS Foundation Trust

London, United Kingdom